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Abstract
Background: Sequential assembly of the human spliceosome on RNA transcripts regulates splicing across the
human transcriptome. The core spliceosome component PRPF8 is essential for spliceosome assembly through its
participation in ribonucleoprotein (RNP) complexes for splice-site recognition, branch-point formation and catalysis.
PRPF8 deficiency is linked to human diseases like retinitis pigmentosa or myeloid neoplasia, but its genome-wide
effects on constitutive and alternative splicing remain unclear.
Results: Here, we show that alterations in RNA splicing patterns across the human transcriptome that occur in
conditions of restricted cellular PRPF8 abundance are defined by the altered splicing of introns with weak 5′ splice
sites. iCLIP of spliceosome components reveals that PRPF8 depletion decreases RNP complex formation at most
splice sites in exon–intron junctions throughout the genome. However, impaired splicing affects only a subset of
human transcripts, enriched for mitotic cell cycle factors, leading to mitotic arrest. Preferentially retained introns and
differentially used exons in the affected genes contain weak 5′ splice sites, but are otherwise indistinguishable from
adjacent spliced introns. Experimental enhancement of splice-site strength in mini-gene constructs overcomes the
effects of PRPF8 depletion on the kinetics and fidelity of splicing during transcription.
Conclusions: Competition for PRPF8 availability alters the transcription-coupled splicing of RNAs in which weak 5′
splice sites predominate, enabling diversification of human gene expression during biological processes like mitosis.
Our findings exemplify the regulatory potential of changes in the core spliceosome machinery, which may be
relevant to slow-onset human genetic diseases linked to PRPF8 deficiency.
Background
The splicing of nascent precursor messenger RNA (pre-
mRNA) molecules to remove introns, and conjoin exons
in different arrangements that potentially encode alter-
native protein isoforms, is fundamental for human gene
expression (reviewed in [1, 2]). This process is carried
out by the human spliceosome machinery, in which over
300 proteins sequentially assemble with uridine-rich
small nuclear RNA molecules (U snRNAs) to form distinct
small nuclear ribonucleoprotein complexes (snRNPs). The
major spliceosome, comprising the U1, U2, U4, U5 and U6
snRNPs, executes >99 % of RNA splicing reactions in
human cells [3]. This machinery recognizes pre-mRNA
sequences at several motifs — the 5′ and 3′ splice sites,
the branch point, and polypyrimidine tracts — positioned
at exon–intron boundaries [4]. Stepwise sequential assem-
bly of spliceosome components on these pre-mRNA motifs
executes splicing reactions. One critical step involves re-
cruitment of the pre-assembled U4/U6.U5 tri-snRNP to
Complex A, which engages 5′ and 3′ splice sites, to form
the pre-catalytic Complex B. Complex B then undergoes
profound structural and conformational changes that lead
to catalytic activation and conversion to Complex Bact,
which initiates catalysis and nucleates the formation of
Complex C, which completes the splicing reaction [3, 4].
Remarkably, the major spliceosome accurately recognizes
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intended splice sites amidst a vast array of distinct exons
and introns that, in metazoans, can range from hundreds
to tens of thousands of base pairs in length [5]. Moreover,
splice site recognition is flexible enough to allow the gener-
ation of a broad range of alternative splicing products [1].
Trans-acting splicing factors, pre-mRNA secondary struc-
ture and chromatin organization are now known to dir-
ectly affect alternative splicing decisions [6]. Moreover,
studies in yeast and other organisms suggest that depletion
of core splicing factors can alter the splicing of subsets of
genes [7–10]. However, it remains unclear what features of
these genes dictate dynamic changes in their recognition
and stepwise processing by spliceosome components to
regulate splice site choice and splicing outcome.
The large ~280-kDa U5 snRNP protein PRPF8 is cen-
tral to the dynamics of spliceosome assembly [11]. It not
only makes direct contacts in the RNA substrate with
the 5′ splice site, the branch point and the polypyrimi-
dine tract in the 3′ splice site, but also engages the U5
and U6 snRNAs [12–20]. Mutations in human PRPF8
that disrupt these interactions, affecting spliceosome as-
sembly and function, are found in autosomal dominant
retinitis pigmentosa, a variable-onset hereditary disease
that results in a progressively decreasing field of vision
due to degeneration of rods and cones [21–26]. Loss-of-
function mutants of human PRPF8 delay the assembly of
spliceosome components on pre-mRNA, and impair the
splicing of 9 % (5 of 57) of tested genes [24]. Moreover,
PRPF8 depletion by RNA interference (RNAi) alters the
pattern of alternative RNA splicing across 10–30 % of 96
known alternative splicing events [24]. Collectively, these
observations raise the possibility that PRPF8 may differ-
entially regulate the stoichiometry and dynamics of spli-
ceosome assembly on different splice sites to modulate
RNA splicing.
Here, we explore the genome-wide effects of human
PRPF8 depletion on RNA splicing using spliceosome UV
crosslinking and immunoprecipitation (iCLIP), which
monitors the assembly of the spliceosome machinery on
pre-mRNA molecules at single nucleotide resolution,
combined with massively parallel sequencing of the tran-
scriptome (RNA-seq) and computational analysis. Con-
sistent with its role as a core spliceosome component
that specifically cross-links with the 5′ splice site [13,
17], PRPF8 depletion decreases the interactions of the
spliceosome machinery with 5′ splice sites in the major-
ity of exon–intron junctions across the human genome.
However, the decreased abundance of PRPF8 triggers
changes in the constitutive and alternative splicing of
only a subset of human transcripts with weak 5′ splice
sites, including many essential for progression through
the mitotic cell cycle, which leads to mitotic arrest.
Notably, these effects are recapitulated via depletion of
Complex B components that closely interact with
PRPF8, whilst this is not the case for further Complex A
and C components. Experimental enhancement of splice
site strength using mini-genes encoding members of this
subset restores comparable to wild type the kinetics and
fidelity of splicing in conditions where PRPF8 abundance
is limiting. Our findings suggest a model wherein com-
petition for the core spliceosome component PRPF8 by
RNA molecules with splice sites of different strength
may control the stepwise assembly of spliceosome com-
ponents to dictate the efficiency, kinetics and outcome
of constitutive and alternative splicing in the human
transcriptome, with implications for the control of bio-
logical processes like mitosis.
Results
Genome-wide decreases in spliceosome assembly at
exon–intron junctions following PRPF8 depletion
To ascertain how PRPF8 abundance affects spliceosome
assembly, we utilized iCLIP [27] to assess pre-mRNA in-
teractions of snRNPs at single nucleotide resolution.
Spliceosome iCLIP provides a global view of protein–
RNA interactions of the spliceosome by employing
immunoprecipitation of the small nuclear ribonucleo-
protein polypeptides B and B1 (SNRPB, also known
as SmB/B'), which are common to all spliceosomal
snRNPs except U6 [28], under conditions that allow
co-purification of other snRNP-associated RNA-binding
proteins (see “Materials and methods” for full details).
We performed spliceosome iCLIP on Cal51 cells de-
pleted of PRPF8 using RNAi. PRPF8 expression was sig-
nificantly decreased by >90 % in Cal51 cells exposed to a
short interfering RNA (siRNA) targeting PRPF8, in com-
parison with a control siRNA, at the level of mRNA
(Additional file 1a) as well as protein (Additional file 1b)
expression.
Spliceosome iCLIP cross-link sites summarized into
genome-wide maps around splice junctions reveal dis-
tinct peaks associated with individual RNA-binding pro-
tein (RBP) occupancy. Changes at multiple positions are
seen in response to PRPF8 depletion (Fig. 1a, b), each of
which signifies interactions that occur relatively late dur-
ing spliceosome assembly (J. Ule, unpublished observa-
tions; see “Materials and methods”). Most notable is the
large reduction in the amplitude of the cross-link peak
located ~20 nucleotides upstream of the 5′ splice site
(Fig. 1a). This motif corresponds to the U5 snRNP binding
site that tethers the 5′ exon following the first steps of
splicing, and is consistent with the reported U5–PRPF8
interaction [29]. Importantly, although we observe a re-
duction in SmB/B’ protein levels following PRPF8 deple-
tion, the amount of RNA going into each library from
each immunoprecipitation reaction is equal, suggesting
that the antibody is limiting rather than the starting ma-
terial (Additional file 1c–e). Furthermore, the observed
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Fig. 1 Genome-wide decreases in spliceosome assembly at exon–intron junctions following PRPF8 depletion. a Spliceosome iCLIP reveals spliceosomal
interactions with pre-mRNA that change following PRPF8 depletion at the 5′ splice site. Spliceosome iCLIP cross-link sites summarized into genome-wide
maps around splice junctions reveal distinct peaks associated with individual RNA-binding protein (RBP) occupancy. A large reduction in
the amplitude of the cross-link peaks located ~20 nucleotides upstream of the 5′ splice site, and immediately adjacent to the exon–intron
junction following PRPF8 depletion is indicated by red arrowheads. b Spliceosome iCLIP reveals spliceosomal interactions with pre-mRNA
that change following PRPF8 depletion at the 3′ splice site. A reduction in the amplitude of the cross-link peak located ~50 nucleotides
upstream of the 3′ splice site following PRPF8 depletion is indicated by red arrowheads
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effects are unlikely to be the result of overall changes in
gene expression following PRPF8 depletion as the distri-
bution of a number of peaks associated with RBP occu-
pancy are unchanged (for example, one peak located ~50
bp upstream of the 5′ splice site, and the majority of peaks
at the 3′ splice site; Fig. 1b). Lastly, the detected differ-
ences persist even after excluding from the analysis genes
that show significant differences in expression levels
between the PRPF8-depleted and control samples
(“Materials and methods”; Additional file 2a, b).
Altered splicing after PRPF8 depletion affects only a
subset of human transcripts
Next, we analyzed the transcriptome of PRPF8-depleted
Cal51 cells by massively parallel RNA sequencing
(“Materials and methods”). Expression levels of in-
tronic reads across the genome of PRPF8-depleted
Cal51 cells are increased in comparison with controls
(p value < 2.2e-16; Fig. 2a), consistent with the role
of PRPF8 in regulating constitutive splicing. Interest-
ingly, PRPF8 depletion significantly alters splicing in
only a subset of human transcripts. We used DEXSeq
(“Materials and methods”) to identify a set of 2086
protein-coding genes that contain at least one retained in-
tron [false discovery rate (FDR) < 0.01] following PRPF8
depletion (Fig. 2b). We also executed DEXSeq on anno-
tated exons (“Materials and methods”) to identify signifi-
cant differences in exon usage in 1921 protein-coding
genes following PRPF8 depletion (Fig. 2b; FDR < 0.01).
Notably, there is a significant overlap between genes that
harbor retained introns and exhibit alternative exon usage
(n = 637; p value < 2.2e-16). Moreover, transcripts with al-
tered splicing patterns constitute only a subset of all
expressed protein-coding genes (n = 3370 out of 13,216;
expression threshold = 1 FPKM (Fragments per kilobase
of exon per million reads mapped); Fig. 2b; see “Materials
and methods”).
We also asked if spliceosomal binding is specifically af-
fected in the subset of introns that are preferentially
retained following PRPF8 depletion. The observed
changes in spliceosome iCLIP peaks around 5′ splice
junctions in response to PRPF8 depletion are broadly
similar in both the subset of retained introns (RI)
and the larger subset of non-retained introns (NRI)
(Additional file 2c). However, the spliceosome cross-
linking pattern at the 3′ splice site changes more in
the RI than the NRI subset (Additional file 2d). In-
deed, we detect an increase in the crosslinking at
the 3′ splice site intron–exon boundary in introns
that are retained (Additional file 2d). One potential
explanation may be that due to delayed tri-snRNP
association, U2AF persists at the 3′ splice site, enhancing
crosslinking that may be normally lost during spliceosome
assembly, until the spliceosome recognizes the 3′ splice
site again during exon ligation. Thus, the decreased spli-
ceosome assembly we observe at 5′ splice sites in the ma-
jority of genomic intron–exon junctions after PRPF8
depletion may trigger more pronounced effects at 3′ splice
sites in the RI subset of introns that are frequently
retained when PRPF8 abundance is limiting. Alternatively,
the increase in crosslinking at the 3′ splice site in-
tron–exon boundary that we observe in introns that
are retained may reflect a more direct role for PRPF8
in 3′ splice site recognition, consistent with cross-
linking data [14–17].
PRPF8 depletion impedes mitotic progression via altered
splicing
Functional enrichment analysis on the subset of tran-
scripts with altered splicing following PRPF8 depletion
reveals that this subset is enriched for transcripts that
participate in mitosis, ubiquitin conjugation, or RNA
processing (Fig. 2c). To address the potential relevance
of PRPF8-induced changes in RNA splicing on biological
processes, we focused on genes encoding proteins with
functions in mitosis, which were highly enriched in the
subset that was sensitive to PRPF8 abundance (Fig. 2c).
Indeed, we previously identified PRPF8 in an RNAi
screen for factors that promote mitotic exit following
drug-induced mitotic arrest [30]. Moreover, multiple
spliceosome components, including PRPF8, were de-
tected in an RNAi screen for factors affecting mitotic
progression [31].
Reverse transcription-polymerase chain reaction (RT-
PCR) and quantitative RT-PCR (qRT-PCR) analysis of
RNA isolated from PRPF8-depleted cells reveals a variety
of splicing defects in transcripts that encode critical fac-
tors required for mitotic progression, including retained
introns (e.g., CDC20, Separase and NUDC), skipped
exons (e.g., ASPM and SKA2), and alternative terminal
exons (e.g., APC8) (Fig. 3a–c; Additional file 3a). Im-
portantly, these alterations do not normally occur during
transit through mitosis in control cells (Additional file
3b, c). Furthermore, they manifest themselves at the pro-
tein level. For example, after PRPF8 depletion there is
decreased expression of CDC20 and separase proteins
(whose transcripts are enriched for retained introns and
presumably destined for nonsense-mediated decay), as
well as in the expression of full-length APC8 protein
(whose transcripts are enriched for an alternative ter-
minal exon) (Fig. 3d).
Consistent with these effects, PRPF8 depletion in
Cal51 cells results in a fivefold increase in the percent-
age of mitotic cells compared with controls (Fig. 4a).
Moreover, U2OS osteosarcoma cells depleted of PRPF8
with two independent siRNAs and monitored by phase-
contrast time-lapse microscopy spend >120 min in mi-
tosis, as opposed to control cells, in which mitosis lasts,
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Fig. 2 (See legend on next page.)
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on average, <60 min (Fig. 4b; Additional file 4a). Live-
cell imaging of U2OS cells stably expressing green fluor-
escent protein (GFP)-tagged histone H2B and depleted
of PRPF8 reveals multiple mitotic abnormalities, includ-
ing unaligned chromosomes, anaphase bridges and
multipolar divisions (Fig. 4c, d). Severe defects in both
chromosome alignment and segregation are also ob-
served in some cells. Collectively, these defects are con-
sistent with the observed mitotic delay. Furthermore,
introduction of properly spliced and processed mRNA
into PRPF8-depleted cells suffices to partially rescue the
observed mitotic defects (Fig. 4e; Additional file 4b),
suggesting that PRPF8 depletion affects mitotic progres-
sion via altered RNA splicing.
Supporting this notion, the depletion of certain add-
itional spliceosome components closely associated with
PRPF8 recapitulates defects in mitotic progression ac-
companied by the altered splicing of mitotic genes. Inde-
pendent depletion of several different components of the
three major spliceosome subcomplexes (A, B, and C)
was verified by qRT-PCR (Additional file 5a). Depletion
of several Complex B components phenocopies PRPF8,
in terms of both defects in splicing of mitotic genes
(Fig. 5a) and, to a lesser extent, mitosis (Fig. 5b; Additional
file 5b, c). Notably, depletion of the spliceosome compo-
nents BRR2 and EFTUD2, which interact directly with
PRPF8 to form the U5 snRNP [32], most strongly pheno-
copy PRPF8 deficiency (Fig. 5b; Additional file 5b, c). In
contrast, depletion of several Complex A or C compo-
nents does not recapitulate the defects in splicing of mi-
totic genes and in mitotic progression observed following
PRFP8 depletion (Fig. 5a, c; Additional file 5b, c).
PRPF8 depletion induces preferential retention of introns,
or inclusion of differentially used exons, with weak 5′
splice sites
What shared characteristics might distinguish the subset
of transcripts whose splicing is altered by PRPF8 deple-
tion? To address this issue, we first evaluated possible
differences in splice site strength between introns that
are retained after PRPF8 depletion and those that are
properly spliced, and we find that inefficiently spliced
introns tend to have weaker 5′ splice sites (p value =
0.0220, Wilcoxon test; Fig. 6a; see “Materials and
methods”). This finding is consistent with prior evidence
suggesting that intron retention correlates with lower
splice site strength [33]. Motif enrichment analysis on
the same set of genes reveals consistent results (Fig. 6b);
while the most frequently identified motifs correspond
to the consensus splice site sequences for both RI
and NRI subsets of genes, the percentage of targets
with such motifs varies significantly between the
two categories (68.50 % for RI versus 91.03 % for
NRI; p value < 2.2 × 10−16, Fisher’s exact test). Not-
ably, such differences are not observed at the 3′
splice site (Additional file 6a, b), which is consistent
with data suggesting that yeast PRPF8 cross-links
most strongly to the 5′ splice site [13, 17, 19]. In
addition, analysis of GC composition reveals that
retained introns have slightly higher GC content
than non-retained introns (p value = 0.0055, Wilcoxon
test; Fig. 6c), with values closer to those of adjacent exons
(p value < 2.2 × 10−16, Wilcoxon test; Fig. 6). This result
agrees with previous findings suggesting that introns with
GC content similar to that of adjacent exons are more
likely to be retained [34]. Next, we determined whether
differences in splice site strength in differentially used
exons could also explain the increase in alternative spli-
cing events that we observe following PRPF8 depletion.
Consistent with the results detected for intron retention
events, differentially used exons harbor weaker 5′ splice
sites (Fig. 6d; Additional file 6c).
Enhancement of splice-site strength renders mini-genes
resistant to PRPF8 depletion
To confirm that splice-site strength determines the out-
come of RNA splicing under conditions where PRPF8
availability is limiting, we generated a mini-gene contain-
ing a full-length intron flanked by two exons within the
CDC20 gene. This particular intron is retained following
PRPF8 depletion as determined by RNA-sequencing ex-
periments and validated by RT-PCR (Figs. 2a and 7a).
(See figure on previous page.)
Fig. 2 Altered splicing after PRPF8 depletion affects only a subset of human transcripts. a Intronic expression levels across the genome are increased in
PRPF8-depleted cells. Normalized intron expression was calculated following analysis of the transcriptome of PRPF8-depleted Cal51 cells using RNA sequen-
cing (left; “Materials and methods”). Statistically significant pairwise comparison is indicated (***p < 0.001). The number of mapped reads, the percentage of
reads that map to exons, exon–intron boundaries, and intron bodies are shown in tabular form (right). b RNA sequencing experiments demonstrate that
PRPF8 depletion results in altered splicing in only a subset of human transcripts. DEXSeq (“Materials and methods”) identifies a set of 2086 protein-coding
genes that contain at least one retained intron [false discovery rate (FDR) < 0.01] and a set of 1921 protein-coding genes that display significant differences
in exon usage (FDR < 0.01) following PRPF8 depletion; 637 genes display both retained introns and alternative exon usage (p < 2.2e-16). Transcripts with al-
tered splicing patterns constitute only a subset of all expressed protein-coding genes (n = 3388 out of 13,216; expression threshold = 1 FPKM (Fragments
per kilobase of exon per million reads mapped); “Materials and methods”). c Functional enrichment analysis using DAVID and WebGestalt (“Materials and
methods”) shows that this subset is enriched for transcripts that participate in mitosis, ubiquitin conjugation, or RNA processing. GO Gene Ontology
Wickramasinghe et al. Genome Biology  (2015) 16:201 Page 6 of 21
Indeed, both the 5′ splice site and the 3′ splice site
encompassing the exon–intron and intron–exon boundar-
ies are weaker than the corresponding consensus se-
quences (Fig. 7a). As predicted, PRPF8 depletion strongly
suppresses removal of this intron in the CDC20 mini-gene
(Fig. 7b, c). Importantly, however, alteration by site-
directed mutagenesis of the weak 5′ splice site into a
strong consensus sequence leads to efficient removal of
this intron in PRPF8-depleted cells, in a manner indistin-
guishable from control siRNA-treated cells (Fig. 7b, c).
Furthermore, strengthening of the polypyrimidine tract
also allows efficient removal of this intron from the
CDC20 mini-gene in PRPF8-depleted cells (Fig. 7b, c;
Additional file 7a–c). Indeed, a number of studies have
Fig. 3 Altered splicing of transcripts encoding proteins required for mitotic progression after PRPF8 depletion. a RT-PCR analysis of RNA from
PRPF8-depleted cells reveals a variety of splicing defects in transcripts that encode critical factors required for mitotic progression, including
retained introns (CDC20 and Separase), and alternative terminal exons (APC8). RT-PCR analysis of CDC20, Separase, and APC8 using the primers
indicated in the schematic are shown alongside the corresponding coverage plots (control siRNA in black, PRPF8 siRNA in red). The
splicing defects are indicated by arrowheads. b, c Quantitative RT-PCR analysis of RNA from PRPF8-depleted cells, including retained introns (CDC20,
Separase, and NUDC), skipped exons (ASPM and SKA2), and alternative terminal exons (APC8). Plots are relative to RNA levels in control siRNA-treated
cells, assigned an arbitrary value of 1, and show the mean of triplicate readings from three independent experiments ± standard error of the mean.
d Protein expression analysis of genes with altered splicing following PRPF8 depletion
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Fig. 4 PRPF8 depletion impedes mitotic progression. a PRPF8 depletion in Cal51 cells results in a fivefold increase in the percentage of
mitotic cells compared with control siRNA-treated cells. Plots show the mean from three independent experiments ± standard error of
the mean. Statistically significant pairwise comparison is shown (***p < 0.001). b U2OS cells stably expressing green fluorescent protein
(GFP)-tagged histone H2B, depleted of PRPF8, and monitored by phase-contrast time-lapse microscopy spend >120 min in mitosis, as opposed to
control siRNA-treated cells, in which mitosis lasts, on average, <60 min. The bar graph depicts time spent in mitosis, measured from nuclear envelope
breakdown to anaphase. c, d Live-cell imaging of U2OS GFP-H2B cells depleted of PRPF8 reveals multiple mitotic abnormalities, including unaligned
chromosomes, anaphase bridges and multipolar divisions, indicated by arrows and arrowheads. Severe defects in both chromosome alignment and
segregation are also observed in some cells. Representative images are shown in (d); defects are quantified in (c). e Introduction of properly spliced
and processed mRNA into PRPF8-depleted cells suffices to partially rescue the observed mitotic defects. Control siRNA-treated and PRPF8-depleted
cells were transfected with properly spliced and processed mRNA and analyzed for mitotic index. Plots represent the mean from three independent
experiments ± standard error of the mean. Statistically significant pairwise comparisons are shown (**p < 0.01, ***p < 0.001)
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suggested that strong 3′ splice sites can compensate for
weak 5′ splice sites [35, 36], although this may also reflect
a role for PRPF8 at the 3′ splice site, consistent with
cross-linking data [14–17]. Thus, the enhancement of
splice site strength renders mini-genes resistant to mis-
splicing provoked by PRPF8 depletion, suggesting that
competition for PRPF8 availability may dictate genome-
wide patterns of RNA splicing.
PRPF8 depletion alters the dynamics of RNA splicing
during transcription
Collectively, our computational and experimental find-
ings suggest that PRPF8 has a rate-limiting function in
the splicing of introns with weak splice sites during
RNA transcription, leading to alternative RNA splicing
patterns in conditions where PRPF8 abundance is re-
stricted. To explore the mechanism behind this function,
Fig. 5 Depletion of Complex B components that interact directly with PRPF8 recapitulate defects in mitotic progression accompanied by the
altered splicing of mitotic genes. a Depletion of Complex A components does not cause defects in either the splicing of mitotic genes (top and
middle panels) or in mitotic progression (bottom panel). Independent depletion of several different components of the three major spliceosome
subcomplexes (A, B, and C) was verified by qRT-PCR (Additional file 5). b Depletion of several Complex B components phenocopies PRPF8, in
terms of both defects in splicing of mitotic genes (top and middle panels) and, to a lesser extent, increased mitotic index (bottom panel). Depletion
of the spliceosome components BRR2 and EFTUD2, which interact directly with PRPF8 to form the U5 snRNP, most strongly phenocopy PRPF8
deficiency. c Depletion of Complex C components does not cause defects in either the splicing of mitotic genes (top and middle panels), or in
mitotic progression (bottom panel). SLU7 partially phenocopies PRPF8 but does not display defects in mitotic progression. For all qRT-PCR experiments
in this figure, plots are relative to RNA levels in control siRNA-treated cells, assigned an arbitrary value of 1, and show the mean of triplicate readings
from at least three independent depletion experiments ± standard error of the mean (SEM). For cell cycle analysis experiments, plots represent the
mean from at least three independent depletion experiments ± SEM
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we analyzed changes in the dynamics of RNA splicing
after PRPF8 depletion using two methods. The first
method evaluates splicing dynamics by comparatively
enumerating the number of intronic reads in different
genes detected by massively parallel RNA sequencing.
The second utilizes a previously described approach that
measures the time between synthesis of a new exon and
the appearance of the splicing product of that exon follow-
ing removal of a reversible transcription inhibitor [37].
Using our RNA sequencing data for poly(A)-selected
transcripts from PRPF8-depleted and control siRNA-
treated cells enabled analysis of the dynamics of the
splicing reaction from intronic reads. Numerous studies
in multiple organisms indicate that splicing is coupled to
Fig. 6 Introns that are retained and exons that are differentially used after PRPF8 depletion have weak 5′ splice sites. a Inefficiently spliced introns
have weaker 5′ splice sites. A set of 200 retained introns (RI) were selected based on fold-change differences (see “Materials and methods”), and
non-retained introns (NRI) within the same set of genes were used as a contrast. A 5′ splice site strength analysis was then carried out as described in
“Materials and methods” for each subset. Statistically significant pairwise comparison is indicated (**p < 0.01). b Motif enrichment analysis on the same
set of genes shows that although the most frequently identified motifs correspond to the consensus splice site sequences for both retained (RI) and
non-retained introns (NRI), the percentage of targets with such motifs varies significantly between the two categories (68.50 % for RI versus 91.03 % for
NRI; p < 2.2 × 10−16, Fisher’s exact test). c Analysis of GC composition reveals that retained introns have higher GC content than non-retained introns
with values closer to those of adjacent exons. Differential GC content was calculated by dividing GC content of each intron to the average of
its adjacent exons (see “Materials and methods”). Statistically significant pairwise comparison is indicated (***p < 0.001). d Differentially
used exons have weaker 5′ splice sites. A 5′ splice site strength analysis was carried out as described in “Materials and methods” for each
subset. Statistically significant pairwise comparison is indicated (***p < 0.001)
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transcription [37–43]. Accordingly, we comparatively
enumerated sequence reads mapped to the first and last
introns for each transcript in PRPF8-depleted versus
control siRNA-treated cells, in order to measure the ex-
tent to which co-transcriptional splicing had been per-
turbed following the depletion of a core spliceosomal
component (Fig. 8a). Specifically, under a scenario of
transcription-coupled splicing, introns located towards
the 5′ end of transcripts are the first to be removed, and
hence are less likely to be present in the transcript by
the time poly(A) tailing occurs. Conversely, introns lo-
cated towards the 3′ end are more likely to be detected,
since their removal may not be completed when polya-
denylation takes place. Consistent with our hypothesis,
we observe that introns located towards the 3′ end of
transcripts are expressed at higher levels than those situ-
ated towards the 5′ end (Fig. 8a, b; Additional file 8a).
Importantly, weak splice sites are not enriched in the
first introns in the set of 2380 genes considered for the
analysis of the co-transcriptional splicing ratio, as ob-
served when plotting the 5′ splice site strength for the
first versus last introns (Additional file 8b). This pro-
vides additional evidence to support the theory that spli-
cing occurs predominantly in concert with transcription
[38]. Moreover, the calculated ratio significantly in-
creases following PRPF8 depletion, suggesting that
changes in the abundance of this core spliceosomal com-
ponent can reduce co-transcriptional splicing efficiency
(Fig. 8c; p value = 5.34 × 10−9).
To experimentally validate these observations, we
measured the kinetics of transcription and splicing
recovery following release from drug-induced tran-
scriptional arrest [37]. Briefly, control siRNA-treated
cells and PRPF8-depleted cells were treated with DRB
Fig. 7 Enhancement of splice-site strength renders the CDC20 mini-gene resistant to PRPF8 depletion. a A mini-gene containing a full-length
intron flanked by two exons within the CDC20 gene. This particular intron is retained following PRPF8 depletion as determined by RNA-sequencing
experiments and the corresponding coverage plot is shown. Both the 5′ splice site and the 3′ splice site encompassing the exon–intron
and intron–exon boundaries are weaker than the corresponding consensus sequences and the sequence of 5′ and 3′ splice mutant constructs are
indicated with changes marked in red. RPKM Reads per kilobase of exon per million reads mapped, WT wild type. b, c Enhancement of splice site
strength renders the CDC20 mini-gene resistant to PRPF8 depletion. PRPF8 depletion strongly suppresses removal of this intron in the
CDC20 mini-gene (left panel). Alteration by site-directed mutagenesis of the weak 5′ splice site into a strong consensus sequence leads
to efficient removal of this intron in PRPF8-depleted cells, in a manner indistinguishable from control siRNA-treated cells (middle panel).
Strengthening of the polypyrimidine tract also allows efficient removal of this intron from the CDC20 mini-gene in PRPF8-deficient cells
(middle panel). Plots in (c) represent quantification of band intensity of spliced and unspliced product using ImageJ (NIH) and represent
the mean percentage of spliced mRNA from three independent experiments ± standard error of the mean. Statistically significant pairwise
comparison is indicated (***p < 0.001); n.s. not significant
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Fig. 8 (See legend on next page.)
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(5,6-dichlorobenzimidazole 1-β-D-ribofuranoside), a re-
versible inhibitor of transcriptional elongation [44]. Total
RNA was then harvested at defined time-points following
DRB removal and the time between synthesis of a new
exon and the appearance of the splicing product of that
exon was measured [37]. We analyzed the kinetics of
splicing in a set of four mitotic genes (ASPM, CDC20,
CDC23, and Separase), in which we had previously identi-
fied intron retention and differential exon usage following
PRPF8 depletion (Fig. 2). Broadly consistent with pub-
lished work [37], we find that all of the introns tested were
spliced and removed within 5–20 minutes of transcription
of the downstream exon in control siRNA-treated cells
(Fig. 8d; Additional file 7c). Interestingly, PRPF8 depletion
affects the kinetics of splicing and intron removal (Fig. 8d;
Additional file 8c). Thus, the delay between detection of
the unspliced nascent transcript and the partially spliced
transcript is ~20 minutes for CDC23 and ~15 minutes for
ASPM in control siRNA-treated cells, but in excess of 40
minutes in PRPF8-depleted cells (Fig. 8d). In contrast, the
kinetics of splicing and removal of intron 1 in the ASPM
transcript (whose intron 19 is affected as shown in Fig. 8)
is similar in control siRNA-treated and PRPF8-depleted
cells (Fig. 8d). The delay between detection of the
unspliced nascent transcript and the partially spliced
transcript is ~15 minutes for ASPM in both control
siRNA-treated and PRPF8-depleted cells, and importantly
the absolute recovery of transcription and splicing is also
similar (Fig. 8d). Furthermore, the delay between detection
of the unspliced nascent transcript and the partially
spliced transcript for UBE2R2, a gene whose splicing was
unaffected by PRPF8 depletion as determined in our
RNA-sequencing data, is similar in both PRPF8-depleted
and control siRNA-treated cells (Additional file 9a). For
all genes tested, there is recovery of transcription follow-
ing release from DRB in both PRPF8-depleted and control
siRNA-treated cells, but the absolute recovery is markedly
lower following PRPF8 depletion. Therefore, to rule out
the possibility that the transcription machinery itself is
affected by PRPF8 depletion, we measured transcription
of the first exon–intron junction of the four target genes
following release from DRB in PRPF8-depleted and con-
trol siRNA-treated cells, and found that the relative rate of
transcription elongation is similar in both conditions
(Additional file 9b). Thus, taken together, our results
provide multiple lines of evidence that PRPF8 has a
rate-limiting function in the splicing of introns with
weak 5′ splice sites during RNA transcription, leading
to alternative RNA splicing patterns in a subset of
human genes, including those encoding several mi-
totic cell cycle proteins, when PRPF8 abundance is
restricted.
Discussion and Conclusions
Our results provide fresh insight into the mechanisms
that enable the human spliceosome to recognize and
sequentially assemble on intended splice sites within a
vast array of transcribed pre-mRNA sequences. We
show that restricting the abundance of PRPF8 — a
key spliceosome component that bridges ribonucleo-
protein complexes mediating splice-site recognition
and catalysis — preferentially alters the splicing of a
subset of human genes that predominantly contain
weak 5′ splice sites. Although studies in yeast and
other organisms have previously suggested that spli-
cing of subsets of genes can be affected by depletion
of various core splicing factors [7–10], we identify
weak 5′ splice sites as one defining characteristic of
(See figure on previous page.)
Fig. 8 PRPF8 depletion alters the dynamics of RNA splicing during transcription. a, b Intronic reads contain potential information on the
dynamics of splicing. Introns located towards the 5′ end of transcripts have a higher probability of being spliced out under a scenario of
co-transcriptional splicing, but this is not the case if splicing occurs post-transcriptionally. A co-transcriptional splicing ratio was calculated
by comparing the intronic coverage of the first versus last introns in each transcript, as indicated in (b), with the values used to calculate
the ratio shown schematically in (a). Such coverage was normalized to take into account intron length and the expression levels of adjacent
exons. A representative example is shown in (a), with first and last intronic reads indicated by arrowheads. RPKM Reads per kilobase of exon per million
reads mapped. c Distribution of the co-transcriptional splicing ratio in control siRNA-treated and PRPF8-depleted samples. Co-transcriptional splicing
dominates in control siRNA-treated samples as indicated by the low ratio values. The co-transcriptional splicing ratio significantly increases following
PRPF8 depletion, suggesting disruptions in the co-transcriptional splicing efficiency (p < 5.34 × 10−9). Only genes with one transcript annotated in
Ensembl 66 were considered for this analysis (n = 2366; “Materials and methods”). d PRPF8 depletion alters the dynamics of RNA splicing
during transcription. The kinetics of transcription and splicing recovery of CDC20, APC8, and ASPM genes following release from drug-induced
transcriptional arrest were measured in control siRNA-treated and PRPF8-depleted cells using a previously published protocol [37]. Primer pairs used
are indicated and were chosen to measure the dynamics of RNA splicing of introns that are either retained or exons that are differentially used as
determined by RNA sequencing experiments. As a control, the kinetics of splicing of an exon that was not differentially used in the ASPM transcript
was also measured. PRPF8 depletion inhibits the kinetics of splicing as the delay between detection of the unspliced nascent transcript
(indicated in black) and the partially spliced transcript (indicated in light gray) is ~20 minutes for CDC23 and ~15 minutes for ASPM in
control siRNA-treated cells, but in excess of 40 minutes in PRPF8-depleted cells. In contrast, the kinetics of splicing and removal of intron
1 in the ASPM transcript is similar in both conditions. mRNA expression levels were normalized to non-DRB-treated cells for each condition
(control siRNA-treated and PRPF8-depleted cells), which were harvested alongside the cells just released from DRB (0 minute time-point). DRB
5,6-dichlorobenzimidazole 1-β-D-ribofuranoside
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the subset of introns affected by restricted PRPF8
abundance. By using spliceosome iCLIP, we demon-
strate that the specificity of PRPF8 depletion on
splicing events strikingly correlates with both weaker
5′ splice sites as well as decreased interaction of the
spliceosome with 5′ splice sites. Interestingly, this
subset is highly enriched for genes that encode factors
essential for RNA processing, ubiquitin conjugation,
or mitotic cell cycle progression, raising questions
concerning the functional significance of their altered
splicing. Indeed, we find that PRPF8 depletion provokes
mitotic arrest in dividing cells, accompanied by intron re-
tention and alternative exon usage in several mitotic
genes, along with reduced abundance of their encoded
proteins. Moreover, we demonstrate that these alterations
are ameliorated by the experimental enhancement of
splice site strength in mini-genes encoding affected in-
trons in mitotic genes. Lastly, we show that PRPF8 deple-
tion alters the dynamics of splicing during transcription.
Our findings have several interesting implications.
We provide additional evidence supporting the idea that
splicing is largely coupled to transcription. This comes
from computational analysis of intronic reads, as well as
experimental analyses. Our computational analysis is con-
sistent with previous genome-wide observations that were
based on the analysis of junction reads [43], and indicate
that it is possible to gain biological knowledge from the in-
tronic data generated in RNA-sequencing experiments,
which are typically not considered for analysis. Notably,
the transcription-coupled splicing ratio is significantly in-
creased following PRPF8 depletion and a number of tran-
scripts display a ratio >1. In these transcripts, intronic
reads for the first intron are greater than those for the last
intron, suggesting that there is an increased likelihood
that these particular transcripts are spliced post-
transcriptionally. This may result in increased compe-
tition for upstream and downstream RNA sequence
elements by the spliceosome, such that strong splice
sites would be favored over weak ones, especially in
conditions where spliceosome assembly and activation
is suboptimal, for example, following PRPF8 depletion.
Thus, a potential change from co-transcriptional to post-
transcriptional splicing may have an effect on the outcome
of the splicing reaction. Taken together with the kinetics
of splicing and intron removal experiments, our findings
suggest that reductions in PRPF8 levels may in part un-
couple transcription from splicing, allowing more time for
introns with weak splice sites to be removed.
Consistent with the observations derived from the spli-
ceosome iCLIP data, RNA-sequencing experiments show
an overall increase in intronic expression levels. How-
ever, defective splicing is detected in only a subset of in-
trons, which present typical characteristics of retained
introns, including weaker 5′ splice sites [45], and lower
differential GC content [34]. Indeed, PRPF8 is one of the
few spliceosomal components that can directly contact
the 5′ splice site, as well as the branch point and part
of the polypyrimidine tract in the 3′ splice site region
[13–20]. In yeast, its interaction with the 5′ splice site has
been reported as being stronger [19], consistent with both
our spliceosome iCLIP results and our splice site strength
and motif analysis. Altogether, these findings suggest that
the splicing alterations we observe are likely to arise from
changes in the equilibrium reached between weak and
strong splice sites in their competition for binding to the
spliceosome, such that stronger 5′ splice sites are favored
when PRPF8 abundance is limiting. Thus, although
spliceosome assembly at 5′ splice sites is affected genome-
wide, a decrease in spliceosomal binding at strong 5′
splice sites would not compromise splicing of the as-
sociated introns. We have validated this hypothesis
with mini-gene experiments, in which we show that
experimental enhancement of splice site strength can
restore the kinetic competition equilibrium following
PRPF8 depletion. On the other hand, although one of the
major phenotypes that we observe in PRPF8-depleted cells
is an increase in intron retention, we also detect an in-
crease in alternative exon usage, raising the possibility that
competition for binding to PRPF8 may regulate alternative
splicing (Fig. 9). Indeed, we also detect weaker 5′ splice
Fig. 9 Model describing role of 5′ splice site strength in determining
constitutive and alternative splicing regulated by PRPF8. In conditions
of abundant PRPF8, there is competition between strong and weak 5′
splice sites to determine splice site choice and spliceosome assembly
is proficient. When PRPF8 is limited, this causes a reduction in
spliceosome assembly, such that strong 5′ splice sites are
favored over weak 5′ splice sites, resulting in altered splicing
patterns in a subset of transcripts
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sites for differentially used exons in PRPF8-depleted
cells. This is consistent with evidence suggesting that
changes in the concentration of core components of
the spliceosome such as SmB/B’ can also regulate this
process [9, 24, 46].
The reduction in cross-linking at 5′ splice sites after
PRPF8 depletion that we observe from our spliceosome
iCLIP data is expected to reflect a decrease in snRNP as-
sociation with the pre-mRNA. An alternative hypothesis
is that PRPF8 depletion leads to a different conformation
of the bound snRNPs that does not allow efficient cross-
linking. The iCLIP protocol is unable to directly evaluate
this in its current format since no structural information
about the RBPs being precipitated is provided by this
technique. Arguing against this alternative hypothesis,
PRPF8 is not required for a minimal U1 snRNP to be
formed [47], whilst a recent study in yeast found that de-
leting the sites of direct interaction between the U1
snRNA with Prp8 had no affect on both U1 snRNA
levels or the protein components of the U1 snRNP [19].
Collectively this suggests that PRPF8 is not required for
U1 snRNP formation and cross-linking, and that the re-
duced signal in our experiments most likely results from
reduced association of the U1 snRNP with the pre-
mRNA targets, rather than through a conformational
change resulting from PRFP8 depletion. However, dis-
rupting the direct interaction between U1 snRNP and
Prp8 in yeast did reduce recruitment of the U4/U6.U5
tri-snRNP and the U2 snRNP during the splicing cycle,
possibly explaining reduced cross-linking at the 3′ splice
site [19]. The mechanisms behind this still remain
unclear.
Our findings are consistent with previous reports that
reductions in the activity or concentration of core
spliceosome components can lead to alterations in the
kinetics of spliceosomal rearrangements and differences
in splice site choice [2, 48–53]. It is important to note
that siRNA-mediated depletion never leads to a complete
depletion of the protein of interest, so in our experiments
there will still be residual PRPF8 protein present in the
cells, albeit at a low level (>90 % reduction in mRNA and
protein levels; Additional file 1). This is supported by our
iCLIP data, which show that PRPF8 depletion results in a
large reduction, but not complete abolition, of the cross-
link peak expected to correspond to the U5 snRNP bind-
ing site located ~10–20 nucleotides upstream of the 5′
splice site (Fig. 1c). Thus, spliceosome assembly/activation
is likely to be severely compromised, but not completely
abrogated in PRPF8-depleted cells. Importantly, our re-
sults suggest that components of Complex B, and more
specifically BRR2 and EFTUD2, which interact directly
with PRPF8 to form the U5 snRNP complex [32], pheno-
copy PRPF8 most strongly. Indeed, spliceosome activation
and disassembly are regulated by both EFTUD2 and BRR2
[54]. Depletion of several Complex A or C components
does not recapitulate the defects in splicing of mitotic
genes and in mitotic progression observed following
PRFP8 depletion, suggesting that it is the U5 snRNP
which is critical for regulating spliceosome dynamics and
the removal of introns that are difficult to splice.
Expression levels of core spliceosome factors can vary
during development, across tissue types and in disease
[10, 55]. Importantly, mutations in both PRPF8 and
BRR2 are found in autosomal dominant retinitis pig-
mentosa [21–26]. It is unclear why mutations in broadly
expressed genes encoding core spliceosomal components
result in a highly tissue-specific pathology with no ap-
parent effects on other cell types. However, several stud-
ies have demonstrated that the expression levels of U5-
snRNP proteins as well as levels of splicing are higher in
the retina [24, 56, 57]. Furthermore, it has been sug-
gested that mutations in U5 snRNP components affect
spliceosome assembly and function and impair the spli-
cing of 9 % (5 of 57) tested genes [24], although the spe-
cific target transcripts are unknown. It remains to be
seen whether mutations in core spliceosomal compo-
nents like PRPF8, as seen in autosomal dominant retin-
itis pigmentosa, also change the kinetic competition
equilibrium between weak and strong splice sites, just as
we observe when PRPF8 is depleted. Such a change may
only result in subtle changes in expression of a subset of
genes, but the cumulative effect of a small change may
manifest over a number of years, consistent with the fact
that retinitis pigmentosa is a gradual-onset disease [58].
Indeed, two recent studies reported that a number of
myeloid neoplasms contain somatic PRPF8 mutations or
hemizygous deletions with associated splicing defects
[59] and a role for PRPF8 in the splicing of genes
required for sister chromatid cohesion [60]. Thus, the
model for spliceosome regulation suggested by our
findings (Fig. 9) has implications for disease patho-
genesis that warrant future investigation.
Materials and methods
Cell culture
Cal51 breast adenocarcinoma and U2OS osteosarcoma
cells were cultured in Dulbecco’s modified Eagle
medium (DMEM; Invitrogen) with 10 % fetal calf serum
(Invitrogen) and 1× penicillin-streptomycin (Invitrogen).
siRNA-mediated depletion, antibodies and western
blotting
For siRNA-mediated depletion, Cal51 cells were reverse
transfected with 25 nM siRNA to the indicated genes
using DharmaFECT1 (Dharmafect) transfection reagent.
Transfected cells were harvested 54 hours later for RNA
extraction, western blotting and fluorescence-activated
cell sorting (FACS). Efficiency of depletion was either
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monitored by western blotting with the indicated
antibodies or by qRT-PCR against the indicated genes.
Antibodies used were anti-PRPF8 (Abcam), anti-
Separase (Abcam), anti-CDC20 (Santa Cruz), anti-
APC8 (Novus Biologicals), anti-Actin (Abcam).
RNA extraction, RT-PCR and qRT-PCR
RNA was isolated from siRNA-treated cells with an
RNeasy kit (Qiagen) according to the manufacturer’s
instructions. Isolated RNA was quantified with a
NanoDrop 1000 (Thermo Scientific) and quality was de-
termined by measuring the A260/A280 ratio, which was
always between 1.8 and 2.1. All RNA was stored at −80°C.
RNA (1 μg) was used for cDNA synthesis using the
QuantiTect Reverse Transcription Kit (Qiagen) according
to the manufacturer’s instructions. Synthesized cDNA was
diluted following reverse transcriptase inactivation and
stored at −20°C. Primers for qPCR were designed to
bridge exon–intron junctions in cases of depletion valid-
ation. For mitosis targets, they were designed to bridge
mis-spliced portions of transcripts as determined by
RNA-sequencing experiments in PRPF8-depleted cells.
For RT-PCR experiments, PCR was conducted on a
MJ Research thermal cycler using Accuprime Pfx
DNA polymerase (Invitrogen), forward and reverse
primer, and cDNA. qPCR was conducted on either
Rotorgene RG-3000 (Corbett Research) or Light Cy-
cler 480 (Roche) machines using 2× SYBR-Green
Master Mix (Roche or Invitrogen), forward and re-
verse primer, and cDNA. The cycling acquisition pro-
gram was as follows: 50 °C 2 minutes, 95 °C 2
minutes, 50 cycles of 95 °C for 15 seconds and 60 °C
for 30 seconds. The Ct values were calculated, refer-
enced to standard curves for each primer set. All
samples were then normalized to control siRNA-
treated samples. Primer sequences are available on
request.
Live cell imaging
For live-cell imaging, U2OS cells were reverse trans-
fected with 25 nM siRNA oligos onto multi-well 1.0-
mm-thick borosilicate chamber slides (Lab-Tek) using
DharmaFECT-1 (Thermo Scientific). Phase-contrast,
multi-point time-lapse microscopy was performed on a
Zeiss Axiovert 200M microscope, acquiring images every
3 minutes under a 20× objective. To visualize chromatin,
GFP-tagged histone H2B was subcloned from pH2B-
GFP (Addgene plasmid 11680) into pcDNA3.1/puro
(a kind gift from Chris Sullivan, University of Texas).
The H2B-GFP transgene was then stably integrated
into U2OS cells, which were selected with 1 μg/ml
puromycin (Invitrogen). Fluorescence live-cell imaging
was performed on a Leica DMI6000 microscope using
a HCX PL APO objective (40× magnification, N.A.
0.85), and images acquired every 5 minutes on an
Evolve 512 EMCCD camera (Photometrics) using LAS
AF software (Leica), then processed and analyzed with
ImageJ (NIH).
Flow cytometry
For determination of mitotic index, cells were fixed in
ethanol, blocked in phosphate-buffered saline (PBS) with
0.1 % Triton X-100 (PBST) and 1 % bovine serum albumin
for 30 minutes, then incubated with mouse anti-phospho-
MPM2 antibody 1:500 (Millipore) for 2 hours at room
temperature. Following washes with blocking solution,
cells were incubated with Alexa Fluor 488 secondary anti-
body (Life Technologies) for 1 hour, washed with PBST
and treated with 40 μg/ml propidium iodide (Sigma) and
200 μg/ml RNaseA (Sigma) before analyzing on a Becton
Dickinson LSR II flow cytometer. Some cells were treated
with 200 ng/ml of nocodazole (Sigma) for 4 or 15 hours
to induce mitotic arrest prior to harvest.
Rescue experiments with fully spliced poly(A)+ mRNA
Poly(A)+ mRNA was purified from the cytoplasm of cul-
tured cells using OligoTex kit (Qiagen) according to the
manufacturer’s protocol. mRNA (2 μg) was then trans-
fected into cells which had been previously transfected
19 hours earlier with control siRNA or PRPF8 siRNA
using TransMessenger transfection reagent (Qiagen) ac-
cording to the manufacturer’s instructions. Cells were
harvested 31 hours post-transfection (50 hours in total)
and analyzed for mitotic index by flow cytometry as
above. Data represent the mean from three independent
experiments ± standard error of the mean (SEM).
Mini-gene experiments
We generated a mini-gene containing a full-length in-
tron flanked by two exons within the CDC20 gene using
PCR to amplify the respective region from genomic
DNA using Accuprime Pfx (Invitrogen) to avoid the
introduction of point mutations. This particular intron is
retained following PRPF8 depletion as determined by
RNA-sequencing experiments and validated by RT-PCR
(Fig. 7a). This sequence was cloned into pcDNA3 (Invi-
trogen) using BamHI and ApaI restriction enzymes. To
make the 5′ splice site mutant, QuikChange II XL Site
Mutagenesis Kit (Stratagene) was used to generate the
following mutation (mutated nucleotides are under-
lined): 5′- CCACAAAATGCGCCAGCAGGTAAGACC
CGAAGTTC. To strengthen the polypyrimidine tract,
we generated a shortened PCR product using either the
5′ primer: GCGTCTAGACTTTTTTTTTTTTTACAG
GTTATCAGAACAGACTG, GCGTCTAGACTCACTC
CGTTTCCACAGGTTATCAGAACAGACTG, GCGTC
TAGACTCACTCCTTTTCCACAGGTTATCAGAACAG
ACTG or GCGTCTAGACTCACTCCGTTTTTACAGG
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TTATCAGAACAGACTG. This product was just down-
stream of an internal XbaI site, and was subcloned into ei-
ther the full-length vector (to generate a 3′ splice mutant)
or the 5′ splice site mutant vector (to generate a double
mutant) using XbaI and ApaI restriction enzymes. All
constructs were verified by sequencing. These constructs
were transfected into cells that had been transfected 24
hours earlier with either control siRNA or PRPF8 siRNA
using JetPrime transfection reagent (Polyplus). Total RNA
was harvested from cells 30 hours post-transfection with
plasmids (54 hours in total) and 1 μg of RNA was used for
cDNA synthesis using the QuantiTect Reverse Transcrip-
tion Kit (Qiagen) according to the manufacturer’s instruc-
tions. RT-PCR experiments were then carried out to
visualize spliced and non-spliced product. Band intensity
was quantified using ImageJ (NIH) and represents the
mean ± SEM from three independent experiments.
Dynamics of RNA splicing
We measured the kinetics of transcription and splicing
recovery following release from drug-induced transcrip-
tional arrest using a previously published protocol [37].
Briefly, control siRNA-treated cells and PRPF8-depleted
cells were treated with DRB, a reversible inhibitor of
transcriptional elongation [44]. Total RNA was then har-
vested at defined time-points following DRB removal
and the time between synthesis of a new exon and the
appearance of the splicing product of that exon was
measured [37]. Cal51 cells were seeded at 1.5 × 105cells/
ml for control siRNA treatment and 2.5 × 105 cells/ml for
PRPF8 siRNA treatment in 2 ml DMEM in order to
ensure an even number of cells for both conditions at
the time of DRB treatment. The indicated siRNAs
were reverse transfected with DharmaFECT according to
the protocol above. Fifty-one hours post-transfection, 100
μM of DRB was added to cells and incubated for 3 hours
to inhibit transcriptional elongation. Fifty-four hours post-
transfection, media was removed, cells were washed twice
with PBS, and 2 ml of new media was added. Cells were
harvested at 5-minute intervals starting 0 minutes after
DRB removal by direct lysis with RLT buffer (Qiagen) and
subsequent vigorous scraping. Lysates were homogenized
with QIAshredder columns (Qiagen) and RNA prepar-
ation with RNeasy kit (Qiagen) followed according to the
manufacturer’s protocol. All subsequent qPCR results
were normalized to non-DRB-treated cells for each condi-
tion (control siRNA-treated and PRPF8-depleted cells),
which were harvested alongside the 0 minute time-point
cells. Primer pairs used are indicated in Fig. 8 and were
chosen to measure the dynamics of RNA splicing of
introns that are either retained or exons that are
differentially used as determined by RNA sequencing
experiments. Primers spanning exon 4: intron 4 of
CDC23, exon 10: intron 10 of CDC20, exon 19: intron 19
and exon 2: intron 2 of ASPM, and exon 19: intron 19 of
Separase were used to measure recovery of transcription
following DRB release. Primers spanning exon 3: intron 4
of CDC23, exon 9: intron 10 of CDC20, exon 18: intron
19 and exon 1: intron 2 of ASPM, and exon 18: intron 19
of Separase were used to measure the appearance of
the partially spliced product following DRB release.
Values represent mean ± SEM from one representa-
tive experiment.
Analysis of the spliceosome iCLIP data
Spliceosome iCLIP datasets for three control-siRNA-
treated and three PRPF8-depleted samples were gener-
ated using the previously described iCLIP protocol [61]
with minor modifications. Briefly, spliceosome iCLIP
was performed with the 12F5 antibody directed against
SmB/B’ (Santa Cruz) at a concentration of 5 μg/ml and
using mild stringency conditions (lysis buffer, 50 mM
Tris–HCl ph 7.4, 0.1 M NaCl, 0.5 % Igepal CA-630, 0.05
% SDS, 0.25 % Na-deoxycholate; wash buffer, 50 mM
Tris–HCl ph 7.4, 0.5 M NaCl, 0.5 % Igepal CA-630, 0.05
% SDS, 0.25 % Na-deoxycholate, 1 mM EDTA). These
reduced stringency conditions allow co-purification of
other snRNP-associated RBPs, leading to distinct peaks
in the summarized genome-wide maps around splice
junctions that are associated with individual RBP occu-
pancies (M. Briese, C. Sibley, J. Ule, unpublished obser-
vation). A complete analysis of the spliceosome iCLIP
method that characterizes individual peaks is beyond the
scope of this manuscript, and will be reported elsewhere
(J. Ule, personal communication).
Each biological replicate was sequenced twice as tech-
nical replicates, resulting in a total of 12 samples. Spli-
ceosome iCLIP libraries contained a four-nucleotide
indexing barcode, and five-nucleotide random barcode
to allow removal of PCR duplicates. The obtained reads
were mapped to the human genome (hg19) with Bowtie
[62] and analyzed as described previously [27]. Bed files
that contain information on spliceosome occupancy
along the genome were generated as a result, and further
used for downstream analysis. iCLIP counts were nor-
malized by library size to account for variations in se-
quencing depth across samples. Similarly, for each
junction, counts were divided by the maximum value
across all libraries to allow for the comparison across
different features.
Analysis of the RNA-seq data
Datasets and mapping
The transcriptome of control siRNA-treated and PRPF8-
depleted Cal51 cells was sequenced on an Illumina
HiSeq2000 platform using 100 bp paired-end reads with
RNA isolated from three and four independent depletion
experiments, respectively. Due to the high quality of the
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reads, raw data were directly mapped to the human gen-
ome (Ensembl 66 [63]) using TopHat v.1.3.3 [64] with
the options –max-multihits 1 –no-novel-juncs –min-
isoform-fraction 0.0, and using the genome annotation
as a guide.
Intron counts and normalized intron expression
Intron coordinates were obtained with custom scripts
based on bedtools v.2.17.0 [65] by considering exons
from transcripts annotated as protein coding in Ensembl
66. Overlapping exons were merged, and the longest
exon or combination of exons was kept. Intronic ex-
pression levels were then obtained with dexseq-count
(DEXSeq v.1.7.0 [66]) and normalized as follows:
μ^i ¼
ci=li
cg=lg
⋅
109
N
where μ^i = normalized expressions for intron i, ci=
counts for intron i, li= length for intron i, cg= counts for
gene g, lg= length for gene g, and N = library size.
Identification of differentially used exons
DEXSeq v.1.7.0 was used to identify genes with differen-
tial exon usage across the two studied conditions. Spe-
cific options include –aggregate=no for the preparation
of the annotation and –paired=yes –stranded=no to
count reads that overlap exons. An FDR threshold of
0.01 was used to assess the significance of the detected
fold changes (Benjamini and Hochberg p value correc-
tion [67]).
Identification of retained introns
Differential intron usage was assessed with DEXSeq
v.1.7.0 with the same options as indicated above. Due
to the overall low number of intronic reads compared
with exonic ones, library size factors were not in-
ferred from intron counts, but from exon counts in-
stead. Differentially used introns with a positive log2
fold change (FDR < 0.01, Benjamini and Hochberg p
value correction) were defined as retained introns
(RI), whilst those that did not fulfill this criterion
were classified as non-retained (NRI). The most ex-
treme intron retention events (i.e., the top 200) were
selected for subsequent analyses based on fold change
information.
Splice site strength was calculated with the MaxEntS-
can algorithm [33] and motif enrichment analysis was
performed with Homer v.2 [68] using a common set of
background sequences. The calculation of differential
GC content in introns versus adjacent exons was per-
formed similarly to [34] by discarding 20 nucleotides
from each end of the introns and 3 nucleotides from the
exons in order to account for splicing signals.
Gene level analyses
A gene was defined as expressed if it is detected above 1
FPKM in any given sample. Gene Ontology enrichment
analyses were performed with DAVID [69] and WebGestalt
[70] using an adjusted p value threshold of 0.01 (Benjamini
and Yekutieli correction [71]) and the set of expressed
genes as a background (n = 13,216). Differential gene
expression was assessed with DESeq v.1.10.1 [72] and
significant changes were evaluated following the criteria
previously used for the analysis of differential splicing
(FDR < 0.01, Benjamini and Hochberg correction).
Co-transcriptional splicing ratio
Co-transcriptional splicing was evaluated by comparing in-
tronic expression levels for the first versus last introns of
each transcript. Given the potential complexity introduced
by alternative splicing events, this analysis was limited to
genes with only one transcript annotated in Ensembl 66.
Genes with less than two introns, those shorter than 300
bp (which would be missed in the size selection step during
library preparation) and those that overlap with other genes
in either strand were also discarded. Altogether, such filter-
ing led to a final set of 2366 genes (i.e., transcripts) that
could be considered in the analysis. Following the identifi-
cation of the first and last introns of each transcript in the
study set, a co-transcriptional splicing ratio was calculated
using the formula detailed in Fig. 8.
Data availability
RNA-seq data can be accessed from the ArrayExpress
database with the following accession number, E-MTAB-
3021.
Additional files
Additional file 1: Validation of PRPF8 depletion. a Validation of PRPF8
depletion by qRTPCR. Results are plotted relative to RNA levels in Control
siRNA-treated cells, assigned an arbitrary value of 1, and show the mean of
triplicate repeats from ten independent experiments ± standard error of the
mean. b Exposure to the specific but not control siRNAs efficiently depletes
PRPF8 protein in Cal51 cells as detected by western blotting with
the indicated antibodies. c, d Characterization of spliceosome iCLIP
experiments. UV-crosslinked Cal51 cells were lysed and subjected to
partial RNase I digestion (low, final dilution of 1:100,000; high, dilution
of 1:5000). Spliceosomal RNPs were immunopurified with anti-SmB/B’
antibody, RNA was 5′ end radiolabeled, and RNPs subjected to denaturing
gel electrophoresis and nitrocellulose transfer, an autoradiogram of which is
shown. Each lane represents an independent depletion experiment. The
interrupted line indicates the area on the nitrocellulose membrane cut out
for purification of crosslinked RNP complexes. e Library stats giving the ratio
of unique cDNA counts to total cDNA counts for each of the libraries
sequenced. The average from three experimental replicates and two
technical replicates for each condition is indicated. (PDF 190 kb)
Additional file 2: Genome-wide decreases in spliceosome assembly
at intron–exon junctions following PRPF8 depletion are independent
of expression levels and intron retention. a, b Genome-wide decreases
in spliceosome assembly following PRPF8 depletion are independent of
expression levels. Spliceosome iCLIP plots around 5′ (a) and 3′ (b) splice site
junctions were generated after excluding differentially expressed genes
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between the PRPF8-depleted and control siRNA-treated populations of cells
from the analysis. c, d Spliceosome iCLIP plots around 5′ (c) and 3′ (d) splice
site junctions were generated using the subset of retained introns (top
panels) and the subset of non-retained introns (bottom panels) in control
siRNA-treated and PRPF8-depleted cells. Relevant peaks around 5′ and 3′
splice site junctions that change in response to PRPF8 depletion are
indicated by red arrowheads. (PDF 128 kb)
Additional file 3: Altered splicing of transcripts encoding proteins
required for mitotic progression after PRPF8 depletion. a RT-PCR
analysis of RNA from PRPF8-depleted cells reveals a variety of splicing
defects in transcripts that encode critical factors required for mitotic
progression, including a retained intron (NUDC) and skipped exons
(ASPM and SKA2). RTPCR analysis of ASPM, NUDC, and SKA2 using the
primers indicated in the schematic are shown alongside the corresponding
sashimi plots (control siRNA in black, PRPF8 siRNA in red). The
splicing defects are indicated by arrowheads and counts spanning
splice site junctions that change in the skipped exons are also
indicated. b, c Splicing alterations in mitotic genes do not normally
occur during transit through mitosis. Cal51 cells treated with nocodazole for
4 or 15 hours to induce mitotic arrest were monitored for mitotic
index (b), and analyzed by qRT-PCR for splicing alterations previously
observed following PRPF8 depletion (see Fig. 2) (c). Plots are relative
to RNA levels in control siRNA-treated cells, assigned an arbitrary
value of 1, and show the mean of triplicate readings from three
independent experiments ± standard error of the mean (SEM).
Mitotic index plots also show the mean from three independent
experiments ± SEM. (PDF 264 kb)
Additional file 4: Validation of mitotic arrest following PRPF8
depletion with two independent siRNAs. a U2OS osteosarcoma cells
depleted of PRPF8 using two independent siRNAs and monitored by
phase-contrast time-lapse microscopy spend significantly longer in mitosis
(measured from nuclear envelope breakdown (NEB) to chromatin
decondensation), as opposed to control cells, in which mitosis lasts,
on average, <60 min. Statistically significant pairwise comparisons
are shown (***p < 0.001). b Introduction of properly spliced and
processed mRNA into Control siRNA-treated cells has no effect on
mitotic index. Control siRNA-treated cells were transfected with
properly spliced and processed mRNA purified from whole cells
and analyzed for mitotic index. Plots represent the mean from two
independent experiments ± standard error of the mean. n.s. not
significant. (PDF 77 kb)
Additional file 5: Depletion of Complex B components that interact
directly with PRPF8 recapitulate defects in mitotic progression. a
Independent depletion of several different components of the three
major spliceosome subcomplexes (A, B, and C) used in Fig. 4 was
verified by qRT-PCR. Plots are relative to RNA levels in control siRNA-treated
cells, assigned an arbitrary value of 1, and show the mean of triplicate readings
from at least three independent experiments ± standard error of the
mean. b Bar graph depicting time spent in mitosis, measured from
nuclear envelope breakdown to anaphase, obtained from live-cell
imaging of U2OS cells stably expressing GFP-tagged histone H2B and
depleted of spliceosome subcomplexes (A, B and C). For simplicity,
cells are classified as spending either less than 60 min in mitosis (black bars), or
>60 minutes (red bars). c Percentage of mitotic cells depleted of spliceosome
subcomplexes (A, B, and C) with defects in chromosome alignment and/or
segregation, as shown in Fig. 4. (PDF 155 kb)
Additional file 6: Inefficiently spliced introns and exons that are
differentially used do not have weaker 3′ splice sites. a Inefficiently
spliced introns do not have weaker 3′ splice sites. A set of 200 retained
introns (RI) were selected based on fold change differences (see “Materials and
methods”), and non-retained introns (NRI) within the same set of genes were
used as a contrast. A 3′ splice site strength analysis was then carried out as
described in “Materials and methods” for each subset. b Motif enrichment
analysis on the same set of genes shows that the most frequently identified
motifs correspond to the consensus 3′ splice site sequences for both retained
(RI) and non-retained introns (NRI) and there is no significant change in the
percentage of targets with such motifs. c Differentially used exons do not have
weaker 3′ splice sites. A 3′ splice site strength analysis was carried out as
described in “Materials and methods” for each subset. (PDF 63 kb)
Additional file 7: Enhancement of 3′ splice-site strength renders
the CDC20 mini-gene resistant to PRPF8 depletion. a A mini-gene
containing a full-length intron flanked by two exons within the CDC20 gene.
This particular intron is retained following PRPF8 depletion as determined
by RNA-sequencing experiments and the corresponding coverage plot is
shown. The 3′ splice site encompassing the intron–exon boundary is weaker
than the corresponding consensus sequence and the sequence of 3′
splice mutant constructs are indicated with changes marked in red.
b, c Enhancement of 3′ splice site strength renders the CDC20 mini-gene
resistant to PRPF8 depletion. PRPF8 depletion strongly suppresses removal
of this intron in the CDC20 mini-gene (left panel). Strengthening of
the polypyrimidine tract allows efficient removal of this intron from
the CDC20 mini-gene in PRPF8-deficient cells (middle panel). Plots in
(c) represent quantification of band intensity of spliced and unspliced
product using ImageJ (NIH) and represent the mean percentage of
spliced mRNA ± standard error of the mean from three independent
experiments. Statistically significant pairwise comparisons are indicated
(*p < 0.05, **p < 0.01). n.s. not significant, WT wild type. (PDF 135 kb)
Additional file 8: PRPF8 depletion alters the dynamics of RNA splicing
during transcription. a Raw data used to calculate co-transcriptional splicing
ratio in Fig. 8a is shown. Normalized intron expression for first introns
(fk, orange) and last introns (fI, blue) is shown for each independent
depletion experiment (three for control siRNA, and four for PRPF8 siRNA).
b The 5′ splice site strength of first and last introns are similar. The 5′ splice
site strength was analyzed as described in “Materials and methods” for the
first and last introns in the 2380 genes considered for the analysis of the
co-transcriptional splicing ratio. The p value is indicated. c PRPF8 depletion
alters the dynamics of RNA splicing during transcription. The kinetics of
transcription and splicing recovery of the Separase gene following
release from drug-induced transcriptional arrest were measured in
control siRNA-treated and PRPF8-depleted cells in a similar fashion
to that shown in Fig. 8d. (PDF 109 kb)
Additional file 9: Transcription initiation is similar in control
siRNA-treated and PRPF8-depleted cells. a Delay between
detection of the unspliced nascent transcript and the partially spliced
transcript for UBE2R2 is similar in both PRPF8-depleted and control
siRNA-treated cells. Kinetics of transcription and splicing recovery for
UBE2R2, a gene whose splicing was unaffected by PRPF8 depletion as
determined in our RNA-sequencing data, following release from
drug-induced transcriptional arrest were measured in control siRNA-
treated and PRPF8-depleted cells in a similar fashion to that shown
in Fig. 8d. b Transcription of the first exon–intron junction of the
four target genes following release from DRB in PRPF8-depleted and
control siRNA-treated cells was measured. Primer pairs used span
exon 1: intron 1 and thus measure transcription initiation following
release from drug-induced transcriptional arrest. (PDF 198 kb)
Abbreviations
bp: base pair; DMEM: Dulbecco’s modified Eagle medium; DRB: 5,6-
dichlorobenzimidazole 1-β-D-ribofuranoside; FDR: false discovery rate;
iCLIP: UV crosslinking and immunoprecipitation; NRI: non-retained intron;
PBS: phosphate-buffered saline; PBST: PBS with 0.1 % Triton X-100;
pre-mRNA: precursor messenger RNA; qRT-PCR: quantitative RT-PCR;
RBP: RNA-binding protein; RI: retained intron; RNAi: RNA interference;
RNP: ribonucleoprotein; RT-PCR: Reverse transcription-polymerase chain
reaction; SEM: standard error of the mean; siRNA: short interfering RNA;
snRNP: small nuclear ribonucleoprotein complex; U snRNA: uridine-rich
small nuclear RNA.
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